The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study

被引：0
|
作者：
Takahiro Toyokawa
Naoshi Kubo
Tatsuro Tamura
Katsunobu Sakurai
Ryosuke Amano
Hiroaki Tanaka
Kazuya Muguruma
Masakazu Yashiro
Kosei Hirakawa
Masaichi Ohira
机构：
[1] Osaka City University Graduate School of Medicine,Department of Surgical Oncology
[2] Osaka City General Hospital,Department of Gastroenterological Surgery
来源：
BMC Cancer | / 16卷
关键词：
Esophageal cancer; Esophagectomy; Prognostic factor; Nutrition; Controlling nutritional status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 35 条
  • [21] Immune-related adverse events as independent prognostic factors for camrelizumab in patients with esophageal squamous cell carcinoma: a retrospective cohort study
    Zhao, Ya-Nan
    Cong, Dan
    Zhang, Wenlong
    Jia, Yuanyuan
    Bai, Yuansong
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (02) : 733 - 743
  • [22] Expression of ACP6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma
    Ando, Takuya
    Ishiguro, Hideyuki
    Kuwabara, Yoshiyuki
    Kimura, Masahiro
    Mitsui, Akira
    Kurehara, Hiroki
    Sugito, Nobuyoshi
    Tomoda, Keisuke
    Mori, Ryota
    Takashima, Nobuhiro
    Ogawa, Ryo
    Fujii, Yoshitaka
    ONCOLOGY REPORTS, 2006, 15 (06) : 1551 - 1555
  • [23] Prognostic effect of preoperative Controlling Nutritional Status score in patients with locally advanced rectal cancer: A two-center, retrospective study
    Lu, Siyi
    Chen, Zhaoyu
    Peng, Ran
    Zhang, Qiuxiang
    Wang, Yuxia
    Li, Xuemin
    Qu, Ruize
    Zhou, Xin
    Fu, Wei
    Sun, Tao
    Wang, Hao
    NUTRITION, 2023, 112
  • [24] Elevation of circulating big endothelin-1: an independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma
    Wenjie Jiao
    Jing Xu
    Jinsheng Zheng
    Yi Shen
    Lesheng Lin
    Jian Li
    BMC Cancer, 8
  • [25] Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion Research
    Ishioka, Nobuki
    Suzuki, Takashi
    Yajima, Satoshi
    Murakami, Kentaro
    Ohkura, Yu
    Fukuda, Takashi
    Yagi, Koichi
    Okamura, Akihiko
    Hoshino, Isamu
    Kunisaki, Chikara
    Nakajima, Yasuaki
    Narumiya, Kosuke
    Ogawa, Ryo
    Shimada, Hideaki
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 28 (03) : 163 - 170
  • [26] Utility of Initial Tumor Reduction as a Prognostic Factor in Esophageal Squamous Cell Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery A Retrospective Cohort Study
    Hagi, Takaomi
    Shiraishi, Osamu
    Nakanishi, Tomoya
    Kohda, Masashi
    Hiraki, Yoko
    Kato, Hiroaki
    Yasuda, Atsushi
    Shinkai, Masayuki
    Imano, Motohiro
    Yasuda, Takushi
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 5064 - 5074
  • [27] p53 is an independent prognostic factor in operable esophageal squamous cell carcinoma: a large-scale study with a long follow-up
    Xiao-Ling Xu
    Wei-Hui Zheng
    Kai-Yi Tao
    Xian-Xing Li
    Wei-Zhen Xu
    Yin Wang
    Shuang-Mei Zhu
    Wei-Min Mao
    Medical Oncology, 2014, 31
  • [28] p53 is an independent prognostic factor in operable esophageal squamous cell carcinoma: a large-scale study with a long follow-up
    Xu, Xiao-Ling
    Zheng, Wei-Hui
    Tao, Kai-Yi
    Li, Xian-Xing
    Xu, Wei-Zhen
    Wang, Yin
    Zhu, Shuang-Mei
    Mao, Wei-Min
    MEDICAL ONCOLOGY, 2014, 31 (11) : 1 - 7
  • [29] Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study
    Dong, Yaqin
    Wang, Fan
    Deng, Jiaying
    Tong, Tong
    Chen, Xiangxun
    Wu, Liming
    Wang, Yichun
    Kang, Mei
    Xu, Yutong
    Shi, Guangjie
    Zhu, Liyang
    BMC CANCER, 2025, 25 (01)
  • [30] The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan
    Yoichiro Tsukada
    Takahiro Higashi
    Hideaki Shimada
    Yoshinori Kikuchi
    Atsuro Terahara
    International Journal of Clinical Oncology, 2018, 23 : 81 - 91
1234